Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

On Jan. 30, the U.S. Food and Drug Administration (FDA ... scientists at Vertex combed through libraries of compounds to find an effective inhibitor to block the opening of the channel. “We screened ...

Racial and ethnic minority patients with severe trauma are less likely to receive airlift services compared with White ...

MARION, Ind. — A 28-year-old man is facing charges after allegedly trying to sell a teenage girl for drugs. In a post on Facebook, the Marion Police Department said officers responded to the 500 block ...

The authors analyzed the existing literature on sugammadex, a drug that encapsulates and inactivates steroidal neuromuscular blocking agents (NMBAs). Published results have demonstrated rapid and ...

State Key Laboratory for Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

At the time, BGR reported that the AI might be able to control your computer on your behalf, similar to what Anthropic and Google want to do with their AI agents. The Operator codename ...

It also had the ability to completely block known junk callers so that you wouldn’t even see the call. Apple’s privacy rules didn’t allow the app to work in the same way on iPhone ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...